These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 10854181)

  • 1. Heat shock proteins and cancer immunotherapy.
    Wang XY; Kaneko Y; Repasky E; Subjeck JR
    Immunol Invest; 2000 May; 29(2):131-7. PubMed ID: 10854181
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heat shock proteins (HSPs) based anti-cancer vaccines.
    Ciocca DR; Cayado-Gutierrez N; Maccioni M; Cuello-Carrion FD
    Curr Mol Med; 2012 Nov; 12(9):1183-97. PubMed ID: 22804241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heat shock protein-peptide complexes in cancer immunotherapy.
    Srivastava PK; Udono H
    Curr Opin Immunol; 1994 Oct; 6(5):728-32. PubMed ID: 7826528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The roles of heat shock proteins in tumor immunity.
    Li Z
    Cancer Chemother Biol Response Modif; 2001; 19():371-83. PubMed ID: 11686024
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunotherapy of cancer using heat shock proteins.
    Manjili MH; Wang XY; Park J; Facciponte JG; Repasky EA; Subjeck JR
    Front Biosci; 2002 Jan; 7():d43-52. PubMed ID: 11779704
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heat shock protein gp96 and cancer immunotherapy.
    Peibin Y; Shude Y; Changzhi H
    Chin Med Sci J; 2002 Dec; 17(4):251-6. PubMed ID: 12901515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heat shock protein--peptide complexes as immunotherapy for human cancer.
    Przepiorka D; Srivastava PK
    Mol Med Today; 1998 Nov; 4(11):478-84. PubMed ID: 9857367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat-shock protein-based anticancer immunotherapy: an idea whose time has come.
    Ménoret A; Chandawarkar R
    Semin Oncol; 1998 Dec; 25(6):654-60. PubMed ID: 9865680
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heat shock proteins and the antitumor T cell response.
    Harada M; Kimura G; Nomoto K
    Biotherapy; 1998; 10(3):229-35. PubMed ID: 9559978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vaccination with heat shock protein-peptide complexes: from basic science to clinical applications.
    Hoos A; Levey DL
    Expert Rev Vaccines; 2003 Jun; 2(3):369-79. PubMed ID: 12903802
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of heat shock protein-peptide complexes on tumor and infectious diseases immunity].
    Meng SD; Gao F; Tien P
    Sheng Wu Gong Cheng Xue Bao; 2000 Jul; 16(4):425-8. PubMed ID: 11051811
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation.
    Murshid A; Gong J; Calderwood SK
    Expert Rev Vaccines; 2008 Sep; 7(7):1019-30. PubMed ID: 18767951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heat shock protein-based cancer vaccines.
    Oki Y; Younes A
    Expert Rev Vaccines; 2004 Aug; 3(4):403-11. PubMed ID: 15270645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer immunotherapy and heat-shock proteins: promises and challenges.
    Manjili MH; Wang XY; MacDonald IJ; Arnouk H; Yang GY; Pritchard MT; Subjeck JR
    Expert Opin Biol Ther; 2004 Mar; 4(3):363-73. PubMed ID: 15006730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heat-shock protein-peptide complex-96 for the treatment of cancer.
    Amato RJ
    Expert Opin Biol Ther; 2007 Aug; 7(8):1267-73. PubMed ID: 17696824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro reconstitution of heat shock protein-peptide complexes for generating peptide-specific vaccines against cancers and infectious diseases.
    Li Z
    Methods; 2004 Jan; 32(1):25-8. PubMed ID: 14624873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heat shock protein-peptide complexes for use in vaccines.
    Heike M; Noll B; Meyer zum Büschenfelde KH
    J Leukoc Biol; 1996 Aug; 60(2):153-8. PubMed ID: 8773575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular chaperones and cancer immunotherapy.
    Wang XY; Facciponte JG; Subjeck JR
    Handb Exp Pharmacol; 2006; (172):305-29. PubMed ID: 16610365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological considerations underlying heat shock protein-mediated cancer vaccine strategies.
    Kelly M; McNeel D; Fisch P; Malkovsky M
    Immunol Lett; 2018 Jan; 193():1-10. PubMed ID: 29129721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer immunotherapy: stress proteins and hyperthermia.
    Manjili MH; Wang XY; Park J; Macdonald IJ; Li Y; Van Schie RC; Subjeck JR
    Int J Hyperthermia; 2002; 18(6):506-20. PubMed ID: 12537751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.